Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.04 USD | +11.59% | +122.01% | -22.64% |
12/04 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
12/04 | Sector Update: Health Care | MT |
Business Summary
Number of employees: 389
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-cash Royalties
73.3
%
| 45 | 46.2 % | 115 | 73.3 % | +153.00% |
License Fees and Milestones
16.0
%
| 5 | 5.1 % | 25 | 16.0 % | +400.00% |
Deferred Research and Development
7.8
%
| 10 | 9.7 % | 12 | 7.8 % | +28.06% |
Other
1.9
%
| 11 | 10.7 % | 3 | 1.9 % | -71.68% |
Research and Development
0.9
%
| 2 | 1.7 % | 1 | 0.9 % | -14.38% |
Clinical Product
0.1
%
| 1 | 0.8 % | 0 | 0.1 % | -84.78% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
98.1
%
| 88 | 89.3 % | 153 | 98.1 % | +75.22% |
Rest of World
1.9
%
| 11 | 10.7 % | 3 | 1.9 % | -71.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 31/94/31 |
Director of Finance/CFO | 58 | 01/96/01 | |
Craig Winter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steven O’Day
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/21/01 |
Homa Yeganegi
CTO | Chief Tech/Sci/R&D Officer | - | 20/23/20 |
Zack Armen
IRC | Investor Relations Contact | - | 01/22/01 |
Human Resources Officer | - | - | |
Eric Humes
PRN | Corporate Officer/Principal | - | 01/22/01 |
Alfred Dadson
PRN | Corporate Officer/Principal | - | 01/16/01 |
Robin Taylor
PRN | Corporate Officer/Principal | - | 20/23/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 31/94/31 |
Director/Board Member | 66 | 17/16/17 | |
Susan Hirsch
BRD | Director/Board Member | 71 | 08/20/08 |
Brian Corvese
BRD | Director/Board Member | 67 | 08/07/08 |
Director/Board Member | 58 | 07/18/07 | |
Timothy Wright
BRD | Director/Board Member | 66 | 07/06/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 31,620 | 0 | 0 | 98.79 % |
Stock B | 1 | 20,946,003 | 20,692,218 ( 98.79 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
MINK THERAPEUTICS, INC. 62.75% | 21,772,863 | 62.75% | 19,769,760 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.64% | 245M | |
+2.19% | 42.75B | |
+47.70% | 41.61B | |
+11.69% | 41.34B | |
-8.83% | 26.59B | |
+6.48% | 25.49B | |
-23.03% | 18.12B | |
+30.28% | 12.24B | |
-2.21% | 11.76B | |
+9.22% | 11B |
- Stock Market
- Equities
- AGEN Stock
- Company Agenus Inc.